Press releases
- 4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
- 4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
- 4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
Key statistics
On Thursday, 4Basebio PLC (88Q:MUN) closed at 15.40, -1.91% below its 52-week high of 15.70, set on Dec 30, 1899.
52-week range
Open | 15.70 |
---|---|
High | 15.70 |
Low | 15.70 |
Bid | -- |
Offer | -- |
Previous close | 15.70 |
Average volume | 220.89 |
---|---|
Shares outstanding | 12.81m |
Free float | 3.89m |
P/E (TTM) | -- |
Market cap | 180.55m GBP |
EPS (TTM) | -0.5094 GBP |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼